Abstract Presentation Information
The 8th International Congress on Vegetarian Nutrition invites researchers, clinicians, dietitians, public health professionals, and students from around the world to submit abstracts for presentation at the Congress, March 14–16, 2027, at Loma Linda University.
Under the theme “Nourishing the Future: The Science and Practice of Plant-Based Eating,” the Congress will highlight emerging research and practical applications across vegetarian and plant-based nutrition, including healthy aging and longevity, chronic disease prevention and management, precision nutrition, foundational plant foods, protein and nutritional adequacy, food systems and sustainability, planetary health, and translating evidence into practice.
The same person can submit a maximum of two abstracts as presenting author.
Abstract Information
- Submission Opens: November 16, 2026
- Submission Deadline: January 11, 2027
- Acceptance Notifications: February 8, 2027
- Congress Registration and Deadline to Accept Short Oral or Poster Presentation: February 12, 2027
- Abstract submission instructions will be available on this page shortly.
Abstracts may include:
Original Research
Unpublished research, including primary analyses and secondary analyses of existing data.
Systematic Reviews and Meta-Analyses
Evidence syntheses addressing important questions related to vegetarian and plant-based nutrition.
Case Reports and Case Studies
Clinical nutrition or lifestyle medicine case reports and vignettes that provide novel insights or disseminate new knowledge gained from clinical practice.
Programs, Interventions, and Policies
Educational programs, community-based interventions, planetary health issues, and policy strategies related to plant-based eating.
Short Oral Presentation
Available only to presenters attending the Congress in person.
Virtual Poster
Available to Congress participants attending in person or online.
Abstracts presented at the 8th ICVN will be available through the Congress virtual platform.
Presenting authors must select at least one and no more than two topical areas most closely associated with their abstract.
- Plant-Based Dietary Patterns and Aging, Longevity, Mortality, and Health Span
Research on plant-based dietary patterns, healthy aging, longevity, mortality, cognitive health, health span, and long-term health outcomes. - Plant-Based Nutrition and Chronic Disease Prevention and Management
Research on the role of plant-based nutrition in the prevention, management, and progression of cardiovascular disease, diabetes, obesity, fatty liver disease, kidney disease, cancer, and other chronic conditions. - Precision Nutrition, Personalized Diets, and Individual Responses to Plant-Based Diets
Research on precision nutrition, multi-omics, genetics, the gut microbiome, metabolomics, proteomics, biomarkers, and factors influencing individual responses to plant-based diets. - Plant Proteins, Nutrient Adequacy, and Dietary Quality
Research on plant protein quantity and quality, essential amino acids, micronutrient adequacy, fatty acids, ultra-processed plant foods, and overall dietary quality. - Foundational Plant Foods and Bioactive Components
Research on whole grains, legumes, nuts, fruits, vegetables, seeds, and their bioactive components, including their roles in cardiometabolic, cognitive, immune, and other health outcomes. - Plant-Based Nutrition, Food Systems, Sustainability, and Planetary Health
Research addressing sustainable diets, food systems, environmental impacts, climate, food choices, health-environment tradeoffs, and connections between human and planetary health. - Implementing Plant-Based Nutrition in Clinical Care and Public Health Practice
Research on translating plant-based nutrition evidence into practice, including clinical care, nutrition counseling, dietary interventions, adherence and behavior change, implementation, public health, policy, dietary guidelines, education, and communication.
Abstract Submission Guidelines and Requirements
Abstracts must be submitted through the 8th ICVN virtual platform submission portal.
The submission portal will open November 3, 2026.
A presenting author may submit up to two abstracts, but each abstract must address different research.
All abstracts must be submitted in English, with grammar and spelling appropriate for presentation at a scientific conference.
Supporting images, tables, and figures are not accepted with abstracts.
The presenting author must register for the Congress, either for the full Congress or for the day of their assigned presentation.
Co-authors do not need to register unless they plan to attend.
Presenters of accepted abstracts must confirm Congress registration and acceptance of their assigned presentation format by February 12, 2027.
1. Abstract Title
Provide a short, specific title in Title Case.
Maximum: 150 characters, excluding spaces.
Preferred Presentation Type
Select one:
Virtual Poster
Short Oral
Indifferent
2. Presenting Author Information
Provide:
First name
Last name
Email address
Phone number
Mailing address
Institution
Credentials/degree
3. Co-Author Information
For each co-author who substantially contributed to the research concept, data collection and analysis, or preparation of the abstract, provide:
First name
Last name
Email address
Institution
Country
Note: Co-authors do not need to register for the 8th ICVN unless they plan to attend.
4. Abstract Body
The abstract body must not exceed 350 words, including AI disclosures and funding sources.
Please use the following headings:
Background/Objectives
Briefly describe the research problem, knowledge gap, and study objective and/or hypothesis.
Methods
Describe the study design, participants or study population, methods, and intervention, if applicable.
Results
Report the main findings, including statistical results where appropriate.
At least preliminary data must be included. Abstracts without results will be rejected.
Conclusions
Summarize the primary findings and their potential significance in one or two sentences. Avoid generalizations.
Funding Sources
List the organizations, institutions, or agencies that funded the research.
AI Disclosures, if applicable
Disclose the use of generative AI or AI-assisted technologies in the writing process, if applicable.
Basic tools used for grammar, spelling, or reference checking do not require disclosure. If there is nothing to disclose, no statement is required.
Authors submitting abstracts to the 8th ICVN are expected to uphold recognized standards of research integrity and responsible scientific reporting.
Authors should:
Accurately represent the research.
Appropriately acknowledge contributions and funding.
Disclose relevant conflicts of interest.
Comply with applicable ethical requirements for research involving human participants or animals.
Ensure the accuracy and integrity of all submitted content, including material prepared using AI-assisted tools.
Please confirm that:
Your abstract body does not exceed 350 words.
Your title is in Title Case and does not exceed 150 characters, excluding spaces.
All required abstract headings are included.
The Results section includes at least preliminary data.
Grammar, spelling, and clarity have been reviewed.
Special characters, such as α and β, display correctly.
All co-authors are listed accurately.
The abstract complies with the Scientific Integrity Policy for Submission of Abstracts.
All abstracts will be peer-reviewed by members of the 8th ICVN Scientific Program Planning Committee.
Reviewers will consider:
Objectives
Methods
Results
Conclusions
Significance
Writing quality
Results must include at least preliminary data.
Presenting authors will be notified by email of abstract acceptance by February 8, 2027. The notification will include programming details such as the abstract presentation number, presentation type, date, time, and location.
Please ensure that your email settings allow messages from [email protected] so important Congress information is not blocked by your spam filter.
Presenters of accepted abstracts must register for either the full Congress or at least the day of their assigned presentation and confirm acceptance of their assigned virtual poster or short oral presentation by February 12, 2027.
Abstract submission opens November 16, 2026. Submission instructions will be available shortly. Questions? Please contact [email protected].
